PRTX
$0.00
Protalex
PRTX
Earnings Whisper ®
N/A
Consensus:  $0.00
Revenue:  N/A
Friday
Dec 18
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when PRTX reports earnings?
Beat
Meet
Miss

Where is PRTX's stock price going from here?
Up
Flat
Down
Stock chart of PRTX
Analysts
Summary of analysts' recommendations for PRTX
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Protalex, Inc. is a biopharmaceutical company. It focused on the development of drugs for treating autoimmune and inflammatory diseases, including rheumatoid arthritis and other forms of arthritis. Protalex, Inc. is based in Summit, New Jersey.
Peers
InterCeptRegeneron PharmaceuticalsVertex PharmaceuticalsBioMarin PharmaceuticalBristol-Myers SquibbZoetisMerck & Co.PfizerJohnson & JohnsonEli Lilly